Kenneth Krogulski - 18 Sep 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
18 Sep 2023
Net transactions value
+$5,883
Form type
4
Filing time
03 Oct 2023, 17:04:01 UTC
Previous filing
19 Sep 2023
Next filing
17 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $568 +280 +0.13% $2.03 216,646 18 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $594 +280 +0.13% $2.12 216,926 19 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $599 +280 +0.13% $2.14 217,206 20 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $638 +280 +0.13% $2.28 217,486 21 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $641 +280 +0.13% $2.29 217,766 22 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $627 +280 +0.13% $2.24 218,046 25 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $580 +280 +0.13% $2.07 218,326 26 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $554 +280 +0.13% $1.98 218,606 27 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $549 +280 +0.13% $1.96 218,886 28 Sep 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $532 +280 +0.13% $1.90 219,166 29 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.